Are you Matthew James Everly?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Education & Training
University of CincinnatiPharmD, 2003
Publications & Presentations
PubMed
- 44 citationsLong‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodiesCarrie A. Schinstock, Andrew Bentall, Byron H. Smith, Lynn D. Cornell, Matthew J Everly
American Journal of Transplantation. 2019-06-01 - 48 citationsPrevalence and Impact of De Novo Donor-Specific Antibodies During a Multicenter Immunosuppression Withdrawal Trial in Adult Liver Transplant RecipientsVadim Jucaud, Abraham Shaked, Michele DesMarais, Peter H. Sayre, Sandy Feng
Hepatology. 2019-03-01 - 16 citationsThe importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's ...Mark D. Stegall, Kenneth Troy Somerville, Matthew J Everly, Roslyn B. Mannon, A. Osama Gaber
American Journal of Transplantation. 2019-03-01
Office
2038 Corinth Ave
Los Angeles, CA 90025Phone+1 310-896-8609
